Velsipity Local Manufacturing in China Gets Priority Review
Everest Medicines’ application to make Velsipity locally in China won priority review; production is anticipated in 2027 at about 50 million tablets a year.
Everest Medicines’ application to make Velsipity locally in China won priority review; production is anticipated in 2027 at about 50 million tablets a year.
Six drones hit Kusum Healthcare's Sumy plant in Ukraine, killing an engineer; co-founder Sanjeev Gupta says it could stay shut for one to two years.
Bayer will invest $2.2 billion in a New Albany, Ohio pharmaceutical campus with about 600 permanent jobs; the first module is due by 2031.